Categories Uncategorized

Earth Science Tech Inc. (ETST) Driving Sustainable Growth on New Technologies, In-House Expertise

  • Earth Science Tech is leveraging AI and other technology, along with the expertise of a focused IT department, to drive sustainable growth and ensure long-term value
  • The company uses technology to drive down costs, improve operational efficiencies, and expand profit margins within its pharmacy and telemedicine platforms
  • ETST also utilizes technology in marketing to increase patient and customer retention and drive brand loyalty
  • During the recent Annual Meeting of Shareholders, CTO Chris Rose explained the company’s tech stack and developments that have enabled it to offer its in-house tools to other clinics as a white-label service

Earth Science Tech (OTCQB: ETST) is a strategic holding company that brings together innovative businesses across the healthcare, pharmacy, technology and telemedicine, real estate, and consumer products spaces. The company employs a dedicated IT infrastructure department, led by Chief Technology Officer Chris Rose, that has enabled it to leverage new technology to cut costs, improve operational efficiencies, and expand profit margins across its pharmacy and telemedicine platforms. These benefits, according to Rose, stem from the company’s strategy to build instead of buy and leverage AI to augment the process.

“We build now instead of buy, supported by advancements in and our leverage of AI. We’ve built our own ETST-wide software and data platform that ties together the three pharmacies, our curative telehealth business, and My Online Consultation doctor’s network into one system,” explained Rose during the August 31 Annual Meeting of Shareholders (https://ibn.fm/WdCCV).

“So, adding a new pharmacy clinic partner or anything is as easy as a quick configuration change. Inside the platform, we’ve automated clerical work and workflow processes in the background, leading to operational efficiencies. We’ve also baked invoicing, shipping, inventory, purchasing, pricing, and other management functions into the new platform. And now it’s become something that we can offer to other clinics as a white-label service.”

“Our lean development team has built all of this at unprecedented pace by leveraging AI tools. We’ve taught it our own engineering best practices and procedures; it works alongside our team within guardrails, thousands of automation tests, and human reviews on every release,” Rose continued. “Leaning into AI has enabled us to change our technology tools to become not only a way to improve efficiency, but as a strategic differentiator, offering new products and services.”

The IT infrastructure department has also enhanced Earth Science Tech’s marketing capabilities, especially given that the company considers patient and customer retention central to its overall marketing success. ETST utilizes Customer Relationship Management (“CRM”) systems and proprietary technology at each of its subsidiaries to provide personalized follow-ups, medication reminders, and targeted wellness.

This holistic approach, the company explains, “not only increases the lifetime value (‘LTV’) of each customer but also reinforces ETST’s position as a comprehensive health and wellness provider” (https://ibn.fm/fyiJL). It also drives brand loyalty across Earth Science Tech’s diverse subsidiaries.

Ultimately, Earth Science Tech remains focused on driving sustainable growth and building long-term value by leveraging technology and the expertise of its lean IT team, guided by its distinct purpose of advancing innovation that integrates all aspects of patient care.

For more information, visit the company’s website at www.EarthScienceTech.com.

NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at https://ibn.fm/ETST

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
Austin, Texas
www.BioMedWire.com
512.354.7000 Office
Editor@BioMedWire.com

BioMedWire is powered by IBN

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

Finding What the Scan Already Captured: Nanox Advances Its AI Business on Two Fronts

Approximately 86,000 vertebral fragility fractures occur annually in the UK, with most remaining undiagnosed. Nanox.AI…

3 hours ago

Regentis Biomaterials and the Shift from Symptom Management to Structural Repair in Knee Cartilage Care

Orthopedic practice is moving away from a model that manages knee pain until the joint…

23 hours ago

Researchers in South Korea Identify New Protein That Controls Brain Cancer Growth

Glioblastoma is the deadliest form of brain cancer due to its aggressive growth rate. Most…

1 day ago

Nanox’s Integrated Imaging Ecosystem: Expanding Access to 3D Imaging and Diagnostics

Roughly two-thirds of the world’s population lacks access to basic imaging technology, and the radiologist…

4 days ago

Quantum BioPharma Ltd. (NASDAQ: QNTM) Receives FDA Green Light to Move Lucid-MS into Phase 2 Testing

The FDA IND approval marks a pivotal step for the company's lead compound, known as…

5 days ago

Why Treating Cancer is So Complicated

Cancer care has evolved over the past decades and one would expect that the more…

5 days ago